Search
Returning search results with filters:
Remove filter for
Category: Biologic or vaccine
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 31 - 45 of 57 items.
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
AlertHealth professional risk communication | 2021-03-31
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
AlertHealth professional risk communication | 2021-03-24
Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
AlertHealth professional risk communication | 2021-03-08
Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-08
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
Authorization of COVISHIELD with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2021-03-01
COVID-19 Vaccine Moderna: Updated English-only Global Vial and Carton Labels and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-22
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
AlertHealth professional risk communication | 2021-02-09
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2020-12-23
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
AlertHealth professional risk communication | 2020-12-18
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
AlertPublic advisory | 2020-12-12
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
AlertHealth professional risk communication | 2020-12-12
Clinical trial looking at the potential use of convalescent plasma to treat COVID-19
AlertPublic advisory | 2020-05-01
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17
Health Canada clarifies position on Platelet Rich Plasma treatments
AlertInformation update | 2019-07-26